ES384611A1 - Procedimiento para la preparacion de una forma medicamento-sa estructurada con liberacion de sustancia activa. - Google Patents

Procedimiento para la preparacion de una forma medicamento-sa estructurada con liberacion de sustancia activa.

Info

Publication number
ES384611A1
ES384611A1 ES384611A ES384611A ES384611A1 ES 384611 A1 ES384611 A1 ES 384611A1 ES 384611 A ES384611 A ES 384611A ES 384611 A ES384611 A ES 384611A ES 384611 A1 ES384611 A1 ES 384611A1
Authority
ES
Spain
Prior art keywords
active substance
excipient
converted
pharmaceutical preparations
strained
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES384611A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Farbwerke Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG, Farbwerke Hoechst AG filed Critical Hoechst AG
Publication of ES384611A1 publication Critical patent/ES384611A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
ES384611A 1969-10-17 1970-10-16 Procedimiento para la preparacion de una forma medicamento-sa estructurada con liberacion de sustancia activa. Expired ES384611A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19691952304 DE1952304A1 (de) 1969-10-17 1969-10-17 Verfahren zur Herstellung einer Arzneiform mit gesteuerter Wirkstoff-Freigabe

Publications (1)

Publication Number Publication Date
ES384611A1 true ES384611A1 (es) 1973-06-01

Family

ID=5748430

Family Applications (1)

Application Number Title Priority Date Filing Date
ES384611A Expired ES384611A1 (es) 1969-10-17 1970-10-16 Procedimiento para la preparacion de una forma medicamento-sa estructurada con liberacion de sustancia activa.

Country Status (10)

Country Link
AR (1) AR193341A1 (enrdf_load_stackoverflow)
AT (1) AT317433B (enrdf_load_stackoverflow)
BE (1) BE757586A (enrdf_load_stackoverflow)
CA (1) CA937866A (enrdf_load_stackoverflow)
DE (1) DE1952304A1 (enrdf_load_stackoverflow)
ES (1) ES384611A1 (enrdf_load_stackoverflow)
FR (1) FR2070141B1 (enrdf_load_stackoverflow)
GB (1) GB1325742A (enrdf_load_stackoverflow)
NL (1) NL7014922A (enrdf_load_stackoverflow)
ZA (1) ZA707072B (enrdf_load_stackoverflow)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU520409B2 (en) * 1977-05-25 1982-01-28 Commonwealth Scientific And Industrial Research Organisation Controlled release composition
DE3124983A1 (de) * 1981-06-25 1983-01-20 Meditest Inst Fuer Medizinisch Arzneiformen zur oralen verabreichung
GB2118040A (en) * 1982-02-15 1983-10-26 Hoechst Uk Ltd Oral anti-diabetic preparation
DE3833446A1 (de) * 1988-10-01 1990-04-05 Hoechst Ag Verfahren zur herstellung von arzneimittelwirkstoff-partikeln mit verbesserten fliess-, lager- und formulierungseigenschaften sowie arzneimittel, die diese arzneimittelwirkstoff-partikeln enthalten

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1175826B (de) * 1959-10-23 1964-08-13 Olin Mathieson Verfahren zur Herstellung von Arzneipraeparaten zur oralen Verabreichung
GB1073718A (en) * 1964-06-25 1967-06-28 Smith Kline French Lab Improvements relating to the production of sustained-release pharmaceutical pellets
NL7004971A (enrdf_load_stackoverflow) * 1969-04-12 1970-10-14

Also Published As

Publication number Publication date
GB1325742A (en) 1973-08-08
CA937866A (en) 1973-12-04
NL7014922A (enrdf_load_stackoverflow) 1971-04-20
FR2070141A1 (enrdf_load_stackoverflow) 1971-09-10
BE757586A (fr) 1971-04-15
FR2070141B1 (enrdf_load_stackoverflow) 1974-04-12
ZA707072B (en) 1971-09-29
DE1952304A1 (de) 1971-05-06
AT317433B (de) 1974-08-26
AR193341A1 (es) 1973-04-23

Similar Documents

Publication Publication Date Title
FR2657257B1 (fr) Procede de preparation de medicaments sous forme de perles.
ES423856A1 (es) Procedimiento para la elaboracion de medicamentos con ce- sion retardada de la sustancia activa en el instestino.
ES2117642T3 (es) Preparado farmaceutico que contiene n-glicofuroles y n-etilen glicoles.
ES488168A0 (es) Proceso para la preparacion de tabletas farmaceuticas o medicinales de administracion oral, con liberacion retardada delagente activo, en tabletas en las que la cantidad de libera-cion del agente activo es predeterminada.
ES321779A1 (es) Un metodo para elaborar composiciones farmaceuticas.
DE2966564D1 (en) Therapeutic compositions with enhanced bioavailability and process for their preparation
DE3271829D1 (en) An allergen dry powder composition and process for its preparation
NL7606908A (nl) Benzofurancarbonzuurderivaten en farmaceutisch preparaat alsmede werkwijze voor het bereiden daarvan.
ES384611A1 (es) Procedimiento para la preparacion de una forma medicamento-sa estructurada con liberacion de sustancia activa.
Rinne et al. Electron microscopic evidence on the significance of the granular and vesicular inclusions of the neurosecretory nerve endings in the median eminence of the rat. I. Ultrastructural alterations after reserpine injection
JPS5726615A (en) Improving method for absorbability of slightly soluble drug
DE2860724D1 (en) Pseudomonic acid c, pharmaceutically acceptable salts or esters thereof, processes for their preparation and pharmaceutical or veterinary compositions containing them
ES297425A1 (es) Procedimiento para preparar composiciones farmaceúticas en forma de tabletas de acción diferida
FR2064794A5 (fr) Procédé et dispositif pour l'administration de médicaments par inhalation
ES449062A1 (es) Procedimiento para la preparacion de composiciones farmaceu-ticas que comprenden debricina heterocoloidal.
FR1472901A (fr) Procédé de préparation de médicaments combinés stables sous forme de capsules
Zunin Marijuana: The drug and the problem.
US4146648A (en) Chemotherapeutic composition
US3140233A (en) Tasteless pharmaceutical composition and process
Hammond et al. Proceedings: Cyclic nucleotides and ethanol withdrawal head-twitches in mice
FR1502314A (fr) Nouveaux esters de l'acide itaconique, polymères de ces esters, et procédés pour leur préparation
CN108542909B (zh) 一种阿司匹林磷脂固化组合物、其制备方法及药物制剂
ES361494A1 (es) Procedimiento para la preparacion de medicamentos con libe-racion prolongada de la sustancia activa.
BE862053A (fr) Peptides contenant de la phenylglycine utiles comme medicaments, procede pour leur preparation et compositions pharmaceutiques en contenant
FR2284326A1 (fr) Nouveaux esters de l'acide 5-n-butylpyridine-2-carboxylique, procede pour leur preparation et compositions pharmaceutiques contenant ces composes